Umbilical cord mesenchymal stem cells: The new gold standard for mesenchymal stem cell-based therapies?

Tissue Engineering - Part B: Reviews

Volumn 20, Issue 5, 2014, Pages 523-544

  El Omar, Reine ^a   Beroud, Jacqueline ^a   Stoltz, Jean Francois ^a,b   Menu, Patrick ^a   Velot, Emilie ^a   Decot, Veronique ^a,b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; FLOWCHARTING; NEURODEGENERATIVE DISEASES; STEM CELLS; TISSUE;

CLINICAL APPLICATION; CLINICAL PRACTICES; FUNCTIONAL PROPERTIES; IMMUNOMODULATORY; MESENCHYMAL STEM CELL; MESENCHYMAL STROMAL CELLS; PERIODONTAL LIGAMENT; UMBILICAL CORDS;

CELL CULTURE;

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CLINICAL PRACTICE; CROHN DISEASE; DEGENERATIVE DISEASE; GENE IDENTIFICATION; GOLD STANDARD; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MESENCHYMAL STEM CELL; MULTIPLE SCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIODONTAL LIGAMENT; PROTEIN EXPRESSION; REVIEW; STEM CELL TRANSPLANTATION; TOOTH PULP; TRANSCRIPTOMICS; UMBILICAL CORD; ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; STANDARDS; WHARTON JELLY;

ANTINEOPLASTIC AGENT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL- AND TISSUE-BASED THERAPY; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; UMBILICAL CORD; WHARTON JELLY;

EID: 84913534624     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2013.0664     Document Type: Review

References (180)

1. Catacchio, I., Berardi, S., Reale, A., De Luisi, A., Racanelli, V., Vacca, A., and Ria, R. Evidence for bone marrow adult stem cell plasticity: properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation. Stem Cells Int 2013, 589139, 2013.
2. Friedman, R., Betancur, M., Boissel, L., Tuncer, H., Cetrulo, C., and Klingemann, H. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant 13, 1477, 2007.
3. Subramanian, A., Shu-Uin, G., Kae-Siang, N., Gauthaman, K., Biswas, A., Choolani, M., Bongso, A., and Chui-Yee, F. Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells. J Cell Biochem 113, 1886, 2012.
4. Troyer, D.L., and Weiss, M.L. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26, 591, 2008.
5. Chen, M.Y., Lie, P.C., Li, Z.L., and Wei, X. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp Hematol 37, 629, 2009.
6. Fong, C.Y., Chak, L.L., Biswas, A., Tan, J.H., Gauthaman, K., Chan, W.K., and Bongso, A. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev 7, 1, 2011.
7. Han, Y.F., Tao, R., Sun, T.J., Chai, J.K., Xu, G., and Liu, J. Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods. Cytotechnology 65, 819, 2013.
8. Dalous, J., Larghero, J., and Baud, O. Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives. Pediatr Res 71, 482, 2012.
9. Xu, Y., Meng, H., Li, C., Hao, M., Wang, Y., Yu, Z., Li, Q., Han, J., Zhai, Q., and Qiu, L. Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization. Stem Cells Dev 19, 1511, 2010.
10. Majore, I., Moretti, P., Stahl, F., Hass, R., and Kasper, C. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev 7, 17, 2011.
11. Hua, J., Gong, J., Meng, H., Xu, B., Yao, L., Qian, M., He, Z., Zou, S., Zhou, B., and Song, Z. Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow. Cell Biol Int 2013 [Epub ahead of print]; DOI: 10.1002/cbin.10188.
12. Kim, S.S., Kwon, D.W., Im, I., Kim, Y.D., Hwang, D.S., Holliday, L.S., Donatelli, R.E., Son, W.S., and Jun, E.S. Differentiation and characteristics of undifferentiated mesenchymal stem cells originating from adult premolar periodontal ligaments. Korean J Orthod 42, 307, 2012.
13. Hsieh, J.Y., Fu, Y.S., Chang, S.J., Tsuang, Y.H., and Wang, H.W. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev 19, 1895, 2010.
14. Yu, S., Long, J., Yu, J., Du, J., Ma, P., Ma, Y., Yang, D., and Fan, Z. Analysis of differentiation potentials and gene expression profiles of mesenchymal stem cells derived from periodontal ligament and Wharton's jelly of the umbilical cord. Cells Tissues Organs 197, 209, 2013.
15. Abu Kasim, N.H., Govindasamy, V., Gnanasegaran, N., Musa, S., Pradeep, P.J., Srijaya, T.C., and Aziz, Z.A. Unique molecular signatures influencing the biological function and fate of post-natal stem cells isolated from different sources. J Tissue Eng Regen Med 2012 [Epub ahead of print]; DOI: 10.1002/term.
16. Lu, L.L., Liu, Y.J., Yang, S.G., Zhao, Q.J., Wang, X., Gong, W., Han, Z.B., Xu, Z.S., Lu, Y.X., Liu, D., Chen, Z.Z., and Han, Z.C. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91, 1017, 2006.
17. Chen, H.C., Lee, Y.S., Sieber, M., Lu, H.T., Wei, P.C., Wang, C.N., Peng, H.H., Chao, A.S., Cheng, P.J., Chang, S.D., Chen, S.J., and Wang, T.H. MicroRNA and messenger RNA analyses of mesenchymal stem cells derived from teeth and the Wharton jelly of umbilical cord. Stem Cells Dev 21, 911, 2012.
18. Bai, J., Hu, Y., Wang, Y.R., Liu, L.F., Chen, J., Su, S.P., and Wang, Y. Comparison of human amniotic fluidderived and umbilical cord Wharton's Jelly-derived mesenchymal stromal cells: characterization and myocardial differentiation capacity. J Geriatr Cardiol 9, 166, 2012.
19. Christodoulou, I., Kolisis, F.N., Papaevangeliou, D., and Zoumpourlis, V. Comparative evaluation of human mesenchymal stem cells of fetal (Wharton's jelly) and adult (adipose tissue) origin during prolonged in vitro expansion: considerations for cytotherapy. Stem Cells Int 2013, 246134, 2013.
20. La Rocca, G., Anzalone, R., and Farina, F. The expression of CD68 in human umbilical cord mesenchymal stem cells: new evidences of presence in non-myeloid cell types. Scand J Immunol 70, 161, 2009.
21. Malgieri, A., Kantzari, E., Patrizi, M.P., and Gambardella, S. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med 3, 248, 2010.
22. Torreggiani, E., Lisignoli, G., Manferdini, C., Lambertini, E., Penolazzi, L., Vecchiatini, R., Gabusi, E., Chieco, P., Facchini, A., Gambari, R., and Piva, R. Role of slug transcription factor in human mesenchymal stem cells. J Cell Mol Med 16, 740, 2012.
23. Zhang, Z.Y., Teoh, S.H., Chong, M.S., Schantz, J.T., Fisk, N.M., Choolani, M.A., and Chan, J. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 27, 126, 2009.
24. Salehinejad, P., Alitheen, N.B., Ali, A.M., Omar, A.R., Mohit, M., Janzamin, E., Samani, F.S., Torshizi, Z., and Nematollahi-Mahani, S.N. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly. In Vitro Cell Dev Biol Anim 48, 75, 2012.
25. Nekanti, U., Rao, V.B., Bahirvani, A.G., Jan, M., Totey, S., and Ta, M. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev 19, 117, 2010.
26. Fong, C.Y., Subramanian, A., Gauthaman, K., Venugopal, J., Biswas, A., Ramakrishna, S., and Bongso, A. Human umbilical cord Wharton's jelly stem cells undergo enhanced chondrogenic differentiation when grown on nanofibrous scaffolds and in a sequential two-stage culture medium environment. Stem Cell Rev 8, 195, 2012.
27. Weiss, M.L., Medicetty, S., Bledsoe, A.R., Rachakatla, R.S., Choi, M., Merchav, S., Luo, Y., Rao, M.S., Velagaleti, G., and Troyer, D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24, 781, 2006.
28. De Kock, J., Najar, M., Bolleyn, J., Al Battah, F., Rodrigues, R.M., Buyl, K., Raicevic, G., Govaere, O., Branson, S., Meganathan, K., Gaspar, J.A., Roskams, T., Sachinidis, A., Lagneaux, L., Vanhaecke, T., and Rogiers, V. Mesoderm-derived stem cells: the link between the transcriptome and their differentiation potential. Stem Cells Dev 21, 3309, 2012.
29. La Rocca, G., Anzalone, R., Corrao, S., Magno, F., Loria, T., Lo Iacono, M., Di Stefano, A., Giannuzzi, P., Marasa, L., Cappello, F., Zummo, G., and Farina, F. Isolation and characterization of Oct-4 +/HLA-G + mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 131, 267, 2009.
30. Zhang, J., Chen, G.H., Wang, Y.W., Zhao, J., Duan, H.F., Liao, L.M., Zhang, X.Z., Chen, Y.D., and Chen, H. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction. Chin Med J (Engl) 125, 3472, 2012.
31. Corrao, S., La Rocca, G., Lo Iacono, M., Zummo, G., Gerbino, A., Farina, F., and Anzalone, R. New frontiers in regenerative medicine in cardiology: the potential of Wharton's jelly mesenchymal stem cells. Curr Stem Cell Res Ther 8, 39, 2013.
32. Hoganson, D.M., Meppelink, A.M., Hinkel, C.J., Goldman, S.M., Liu, X.H., Nunley, R.M., Gaut, J.P., and Vacanti, J.P. Differentiation of human bone marrow mesenchymal stem cells on decellularized extracellular matrix materials. J Biomed Mater Res A 2013 [Epub ahead of print]; DOI: 10.1002/jbm.a.34941.
33. Park, J.S., Shim, M.S., Shim, S.H., Yang, H.N., Jeon, S.Y., Woo, D.G., Lee, D.R., Yoon, T.K., and Park, K.H. Chondrogenic potential of stem cells derived from amniotic fluid, adipose tissue, or bone marrow encapsulated in fibrin gels containing TGF-beta3. Biomaterials 32, 8139, 2011.
34. Vishnubalaji, R., Al-Nbaheen, M., Kadalmani, B., Aldahmash, A., and Ramesh, T. Comparative investigation of the differentiation capability of bone-marrow- and adipose-derived mesenchymal stem cells by qualitative and quantitative analysis. Cell Tissue Res 347, 419, 2013.
35. Arminan, A., Gandia, C., Bartual, M., Garcia-Verdugo, J.M., Lledo, E., Mirabet, V., Llop, M., Barea, J., Montero, J.A., and Sepulveda, P. Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissuespecific mesenchymal stem cells. Stem Cells Dev 18, 907, 2009.
36. Hu, L., Hu, J., Zhao, J., Liu, J., Ouyang, W., Yang, C., Gong, N., Du, L., Khanal, A., and Chen, L. Side-by-side comparison of the biological characteristics of human umbilical cord and adipose tissue-derived mesenchymal stem cells. Biomed Res Int 2013, 438243, 2013.
37. Osathanon, T., Sawangmake, C., Nowwarote, N., and Pavasant, P. Neurogenic differentiation of human dental pulp stem cells using different induction protocols. Oral Dis 2013 [Epub ahead of print]; DOI: 10.1111/odi.12119.
38. Kadar, K., Kiraly, M., Porcsalmy, B., Molnar, B., Racz, G.Z., Blazsek, J., Kallo, K., Szabo, E.L., Gera, I., Gerber, G., and Varga, G. Differentiation potential of stem cells from human dental origin-promise for tissue engineering. J Physiol Pharmacol 60 Suppl 7, 167, 2009.
39. Carnevale, G., Riccio, M., Pisciotta, A., Beretti, F., Maraldi, T., Zavatti, M., Cavallini, G.M., La Sala, G.B., Ferrari, A., and De Pol, A. In vitro differentiation into insulin-producing beta-cells of stem cells isolated from human amniotic fluid and dental pulp. Dig Liver Dis 45, 669, 2013.
40. Martinez, C., Rath, S., Van Gulden, S., Pelaez, D., Alfonso, A., Fernandez, N., Kos, L., Cheung, H., and Ramaswamy, S. Periodontal ligament cells cultured under steady-flow environments demonstrate potential for use in heart valve tissue engineering. Tissue Eng Part A 19, 458, 2013.
41. de Lara Janz, F., Favero, G.M., Bohatch, M.S., Jr., Aguiar Debes, A., and Bydlowski, S.P. Simvastatin induces osteogenic differentiation in human amniotic fluid mesenchymal stem cells (AFMSC). Fundam Clin Pharmacol 2012 [Epub ahead of print]; DOI: 10.1111/fcp.12006.
42. Benavides, O.M., Petsche, J.J., Moise, K.J., Jr., Johnson, A., and Jacot, J.G. Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells. Tissue Eng Part A 18, 1123, 2012.
43. Hartmann, K., Raabe, O., Wenisch, S., and Arnhold, S. Amniotic fluid derived stem cells give rise to neuron-like cells without a further differentiation potential into retinalike cells. Am J Stem Cells 2, 108, 2013.
44. Baksh, D., Yao, R., and Tuan, R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25, 1384, 2007.
45. Jo, C.H., Yoon, P.W., Kim, H., Kang, K.S., and Yoon, K.S. Comparative evaluation of in vivo osteogenic differentiation of fetal and adult mesenchymal stem cell in rat critical-sized femoral defect model. Cell Tissue Res 353, 41, 2013.
46. Kim, S.H., Abbasi, F., Lamendola, C., Reaven, G.M., and McLaughlin, T. Glucose-stimulated insulin secretion in gastric bypass patients with hypoglycemic syndrome: no evidence for inappropriate pancreatic beta-cell function. Obes Surg 20, 1110, 2012.
47. Tsai, P.J., Wang, H.S., Shyr, Y.M., Weng, Z.C., Tai, L.C., Shyu, J.F., and Chen, T.H. Transplantation of insulinproducing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats. J Biomed Sci 19, 47, 2012.
48. Wang, H.S., Shyu, J.F., Shen, W.S., Hsu, H.C., Chi, T.C., Chen, C.P., Huang, S.W., Shyr, Y.M., Tang, K.T., and Chen, T.H. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice. Cell Transplant 20, 455, 2011.
49. Bianco, P., Cao, X., Frenette, P.S., Mao, J.J., Robey, P.G., Simmons, P.J., and Wang, C.Y. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 19, 35, 2013.
50. Bollini, S., Gentili, C., Tasso, R., Anderson, K.S., and Cancedda, R. The regenerative role of the fetal and adult stem cell secretome. J Clin Med 2, 302, 2013.
51. Doorn, J., Moll, G., Le Blanc, K., van Blitterswijk, C., and de Boer, J. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev 18, 101, 2011.
52. Fernandez Vallone, V.B., Romaniuk, M.A., Choi, H., Labovsky, V., Otaegui, J., and Chasseing, N.A. Mesenchymal stem cells and their use in therapy: what has been achieved? Differentiation 85, 1, 2013.
53. Pourrajab, F., Forouzannia, S.K., and Tabatabaee, S.A. Molecular characteristics of bone marrow mesenchymal stem cells, source of regenerative medicine. Int J Cardiol 163, 125, 2013.
54. Stubbendorff, M., Deuse, T., Hua, X., Phan, T.T., Bieback, K., Atkinson, K., Eiermann, T.H., Velden, J., Schroeder, C., Reichenspurner, H., Robbins, R.C., Volk, H.D., and Schrepfer, S. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue. Stem Cells Dev 22, 2619, 2013.
55. Patel, D.M., Shah, J., and Srivastava, A.S. Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int 2013, 496218, 2013.
56. Hass, R., Kasper, C., Bohm, S., and Jacobs, R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissuederived MSC. Cell Commun Signal 9, 12, 2011.
57. Ryan, J.M., Barry, F.P., Murphy, J.M., and Mahon, B.P. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2, 8, 2005.
58. De Miguel, M.P., Fuentes-Julian, S., Blazquez-Martinez, A., Pascual, C.Y., Aller, M.A., Arias, J., and Arnalich-Montiel, F. Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med 12, 574, 2012.
59. Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y., Tompkins, R.G., Kobayashi, N., and Yarmush, M.L. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 19, 667, 2010.
60. English, K., French, A., and Wood, K.J. Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 7, 431, 2010.
61. Uccelli, A., Moretta, L., and Pistoia, V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8, 726, 2008.
62. Maitra, B., Szekely, E., Gjini, K., Laughlin, M.J., Dennis, J., Haynesworth, S.E., and Koc, O.N. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33, 597, 2004.
63. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M.E., Remberger, M., Dini, G., Egeler, R.M., Bacigalupo, A., Fibbe, W., and Ringden, O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371, 1579, 2008.
64. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., and Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439, 2004.
65. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P.D., Matteucci, P., Grisanti, S., and Gianni, A.M. Human bone marrow stromal cells suppress Tlymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838, 2002.
66. Tse, W.T., Pendleton, J.D., Beyer, W.M., Egalka, M.C., and Guinan, E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389, 2003.
67. Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S.E., and Ringden, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57, 11, 2003.
68. Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A.I., Zhao, R.C., and Shi, Y. Mesenchymal stem cellmediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2, 141, 2008.
69. Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., and Dazzi, F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101, 3722, 2003.
70. Aggarwal, S., and Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815, 2005.
71. Ghannam, S., Pene, J., Torcy-Moquet, G., Jorgensen, C., and Yssel, H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol 185, 302, 2010.
72. Ren, G., Zhao, X., Zhang, L., Zhang, J., L'Huillier, A., Ling, W., Roberts, A.I., Le, A.D., Shi, S., Shao, C., and Shi, Y. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 184, 2321, 2010.
73. Glennie, S., Soeiro, I., Dyson, P.J., Lam, E.W., and Dazzi, F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105, 2821, 2005.
74. Pierdomenico, L., Bonsi, L., Calvitti, M., Rondelli, D., Arpinati, M., Chirumbolo, G., Becchetti, E., Marchionni, C., Alviano, F., Fossati, V., Staffolani, N., Franchina, M., Grossi, A., and Bagnara, G.P. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 80, 836, 2005.
75. Demircan, P.C., Sariboyaci, A.E., Unal, Z.S., Gacar, G., Subasi, C., and Karaoz, E. Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems. Cytotherapy 13, 1205, 2011.
76. Makino, Y., Yamaza, H., Akiyama, K., Ma, L., Hoshino, Y., Nonaka, K., Terada, Y., Kukita, T., Shi, S., and Yamaza, T. Immune therapeutic potential of stem cells from human supernumerary teeth. J Dent Res 92, 609, 2013.
77. Weiss, M.L., Anderson, C., Medicetty, S., Seshareddy, K.B., Weiss, R.J., Vander Werff, I., Troyer, D., and McIntosh, K.R. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26, 2865, 2008.
78. Yoo, K.H., Jang, I.K., Lee, M.W., Kim, H.E., Yang, M.S., Eom, Y., Lee, J.E., Kim, Y.J., Yang, S.K., Jung, H.L., Sung, K.W., Kim, C.W., and Koo, H.H. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259, 150, 2009.
79. Tipnis, S., Viswanathan, C., and Majumdar, A.S. Immunosuppressive properties of human umbilical cordderived mesenchymal stem cells: role of B7-H1 and IDO. Immunol Cell Biol 88, 795, 2010.
80. Manochantr, S., U-pratya, Y., Kheolamai, P., Rojphisan, S., Chayosumrit, M., Tantrawatpan, C., Supokawej, A., and Issaragrisil, S. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord. Intern Med J 43, 430, 2013.
81. Franquesa, M., Hoogduijn, M.J., Bestard, O., and Grinyo, J.M. Immunomodulatory effect of mesenchymal stem cells on B cells. Front Immunol 3, 212, 2012.
82. Ji, Y.R., Yang, Z.X., Han, Z.B., Meng, L., Liang, L., Feng, X.M., Yang, S.G., Chi, Y., Chen, D.D., Wang, Y.W., and Han, Z.C. Mesenchymal stem cells support proliferation and terminal differentiation of B cells. Cell Physiol Biochem 30, 1526, 2012.
83. Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G.L., Pistoia, V., and Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107, 367, 2006.
84. Che, N., Li, X., Zhou, S., Liu, R., Shi, D., Lu, L., and Sun, L. Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation. Cell Immunol 274, 46, 2012.
85. Rasmusson, I., Le Blanc, K., Sundberg, B., and Ringden, O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol 65, 336, 2007.
86. Traggiai, E., Volpi, S., Schena, F., Gattorno, M., Ferlito, F., Moretta, L., and Martini, A. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 26, 562, 2008.
87. Vivier, E., Raulet, D.H., Moretta, A., Caligiuri, M.A., Zitvogel, L., Lanier, L.L., Yokoyama, W.M., and Ugolini, S. Innate or adaptive immunity? The example of natural killer cells. Science 331, 44, 2011.
88. Boissel, L., Tuncer, H.H., Betancur, M., Wolfberg, A., and Klingemann, H. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells. Biol Blood Marrow Transplant 14, 1031, 2008.
89. Rasmusson, I., Ringden, O., Sundberg, B., and Le Blanc, K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76, 1208, 2003.
90. Spaggiari, G.M., Capobianco, A., Becchetti, S., Mingari, M.C., and Moretta, L. Mesenchymal stem cellnatural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107, 1484, 2006.
91. Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V.M., Allan, D.S., Makadzange, A., Rowland-Jones, S., Willcox, B., Jones, E.Y., van der Merwe, P.A., Kumagai, I., and Maenaka, K. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 100, 8856, 2003.
92. Favier, B., Lemaoult, J., Lesport, E., and Carosella, E.D. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J 24, 689, 2010.
93. Spaggiari, G.M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M.C., and Moretta, L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111, 1327, 2008.
94. Zhao, Y., Cao, D., and Chen, W. [Regulation of mesenchymal stem cells derived from umbilical cord on natural killer cells-mediated cytotoxicity against dendritic cells]. Nan Fang Yi Ke Da Xue Xue Bao 33, 121, 2013.
95. Ribeiro, A., Laranjeira, P., Mendes, S., Velada, I., Leite, C., Andrade, P., Santos, F., Henriques, A., Graos, M., Cardoso, C.M., Martinho, A., Pais, M., da Silva, C., Cabral, J., Trindade, H., and Paiva, A. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Res Ther 4, 125, 2013.
96. Nauta, A.J., Kruisselbrink, A.B., Lurvink, E., Willemze, R., and Fibbe, W.E. Mesenchymal stem cells inhibit generation and function of both CD34 + -derived and monocyte-derived dendritic cells. J Immunol 177, 2080, 2006.
97. Spaggiari, G.M., Abdelrazik, H., Becchetti, F., and Moretta, L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113, 6576, 2009.
98. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E., and Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214, 2005.
99. Saeidi, M., Masoud, A., Shakiba, Y., Hadjati, J., Mohyeddin Bonab, M., Nicknam, M.H., Latifpour, M., and Nikbin, B. Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocytederived dendritic cells. Iran J Allergy Asthma Immunol 12, 37, 2013.
100. Vija, L., Farge, D., Gautier, J.F., Vexiau, P., Dumitrache, C., Bourgarit, A., Verrecchia, F., and Larghero, J. Mesenchymal stem cells: stem cell therapy perspectives for type 1 diabetes. Diabetes Metab 35, 85, 2009.
101. Hass, R., and Otte, A. Mesenchymal stem cells as allround supporters in a normal and neoplastic microenvironment. Cell Commun Signal 10, 13, 2012.
102. Casiraghi, F., Noris, M., and Remuzzi, G. Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation. Curr Opin Organ Transplant 15, 731, 2010.
103. Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C., and Noel, D. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 1, 2, 2010.
104. Meisel, R., Zibert, A., Laryea, M., Gobel, U., Daubener, W., and Dilloo, D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103, 4619, 2004.
105. Prasanna, S.J., and Jahnavi, V.S. Wharton's jelly mesenchymal stem cells as off-the-shelf cellular therapeutics: a closer look into their regenerative and immunomodulatory properties. Open Tissue Eng Regen Med J 4, 28, 2011.
106. Than, N.G., Romero, R., Erez, O., Weckle, A., Tarca, A.L., Hotra, J., Abbas, A., Han, Y.M., Kim, S.S., Kusanovic, J.P., Gotsch, F., Hou, Z., Santolaya-Forgas, J., Benirschke, K., Papp, Z., Grossman, L.I., Goodman, M., and Wildman, D.E. Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance. Proc Natl Acad Sci U S A 105, 15819, 2008.
107. Carosella, E.D., Moreau, P., Le Maoult, J., Le Discorde, M., Dausset, J., and Rouas-Freiss, N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 81, 199, 2003.
108. Vogiagis, D., and Salamonsen, L.A. Review: the role of leukaemia inhibitory factor in the establishment of pregnancy. J Endocrinol 160, 181, 1999.
109. Najar, M., Raicevic, G., Boufker, H.I., Fayyad-Kazan, H., De Bruyn, C., Meuleman, N., Bron, D., Toungouz, M., and Lagneaux, L. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng Part A 16, 3537, 2010.
110. Prasanna, S.J., Gopalakrishnan, D., Shankar, S.R., and Vasandan, A.B. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 5, e9016, 2010.
111. Selmani, Z., Naji, A., Gaiffe, E., Obert, L., Tiberghien, P., Rouas-Freiss, N., Carosella, E.D., and Deschaseaux, F. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 87, S62, 2009.
112. Lee, J.M., Jung, J., Lee, H.J., Jeong, S.J., Cho, K.J., Hwang, S.G., and Kim, G.J. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol 13, 219, 2012.
113. Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., Borg, C., Saas, P., Tiberghien, P., Rouas-Freiss, N., Carosella, E.D., and Deschaseaux, F. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 + CD25high FOXP3 + regulatory T cells. Stem Cells 26, 212, 2008.
114. La Rocca, G., Corrao, S., Lo Iacono, M., Corsello, T., Farina, F., and Anzalone, R. Novel immunomodulatory makers expressed by human WJ-MSC: and updated review in regenerative and reparative medicine. Open Tissue Eng Regen Med J 5, 50, 2012.
115. Marquez-Curtis, L.A., and Janowska-Wieczorek, A. Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 Axis. Biomed Res Int 2013, 15, 2013.
116. Balasubramanian, S., Venugopal, P., Sundarraj, S., Zakaria, Z., Majumdar, A.S., and Ta, M. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells. Cytotherapy 14, 26, 2012.
117. Sohni, A., and Verfaillie, C.M. Mesenchymal stem cells migration homing and tracking. Stem Cells Int 2013, 130763, 2013.
118. Ries, C., Egea, V., Karow, M., Kolb, H., Jochum, M., and Neth, P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109, 4055, 2007.
119. Chute, J.P. Stem cell homing. Curr Opin Hematol 13, 399, 2006.
120. Nourshargh, S., and Marelli-Berg, F.M. Transmigration through venular walls: a key regulator of leukocyte phenotype and function. Trends Immunol 26, 157, 2005.
121. Mishima, Y., and Lotz, M. Chemotaxis of human articular chondrocytes and mesenchymal stem cells. J Orthop Res 26, 1407, 2008.
122. Chamberlain, G., Fox, J., Ashton, B., and Middleton, J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25, 2739, 2007.
123. Kalluri, R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3, 422, 2003.
124. Birkedal-Hansen, H., Moore, W.G., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J.A. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4, 197, 1993.
125. Mandal, M., Mandal, A., Das, S., Chakraborti, T., and Sajal, C. Clinical implications of matrix metalloproteinases. Mol Cell Biochem 252, 305, 2003.
126. Lipari, L., Mauro, A., Tortorici, S., Burruano, F., Leone, A., Spatola, G.F., Gerbino, A., Buscemi, M., and Tete, S. Immunohistochemical and transcriptional expression of the matrix metalloproteinases MMP-2 and MMP-9 in normal and pathological human oral mucosa. J Biol Regul Homeost Agents 23, 259, 2009.
127. Schneider, R.K., Puellen, A., Kramann, R., Raupach, K., Bornemann, J., Knuechel, R., Perez-Bouza, A., and Neuss, S. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials 31, 467, 2010.
128. Mauro, A., Buscemi, M., and Gerbino, A. Immunohistochemical and transcriptional expression of matrix metalloproteinases in full-term human umbilical cord and human umbilical vein endothelial cells. J Mol Histol 41, 367, 2010.
129. Stagg, J. Mesenchymal stem cells in cancer. Stem Cell Rev 4, 119, 2008.
130. Ljujic, B., Milovanovic, M., Volarevic, V., Murray, B., Bugarski, D., Przyborski, S., Arsenijevic, N., Lukic, M.L., and Stojkovic, M. Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice. Sci Rep 3, 2298, 2013.
131. Torsvik, A., and Bjerkvig, R. Mesenchymal stem cell signaling in cancer progression. Cancer Treat Rev 39, 180, 2013.
132. Mandel, K., Yang, Y., Schambach, A., Glage, S., Otte, A., and Hass, R. Mesenchymal stem cells (MSC) directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo. Stem Cells Dev 22, 3114, 2013.
133. Studeny, M., Marini, F.C., Champlin, R.E., Zompetta, C., Fidler, I.J., and Andreeff, M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62, 3603, 2002.
134. Studeny, M., Marini, F.C., Dembinski, J.L., Zompetta, C., Cabreira-Hansen, M., Bekele, B.N., Champlin, R.E., and Andreeff, M. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96, 1593, 2004.
135. Mishra, P.J., Humeniuk, R., Medina, D.J., Alexe, G., Mesirov, J.P., Ganesan, S., Glod, J.W., and Banerjee, D. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68, 4331, 2008.
136. Spaeth, E.L., Dembinski, J.L., Sasser, A.K., Watson, K., Klopp, A., Hall, B., Andreeff, M., and Marini, F. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4, e4992, 2009.
137. Shinagawa, K., Kitadai, Y., Tanaka, M., Sumida, T., Kodama, M., Higashi, Y., Tanaka, S., Yasui, W., and Chayama, K. Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer 127, 2323, 2010.
138. Patel, S.A., Meyer, J.R., Greco, S.J., Corcoran, K.E., Bryan, M., and Rameshwar, P. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol 184, 5885, 2010.
139. Amariglio, N., Hirshberg, A., Scheithauer, B.W., Cohen, Y., Loewenthal, R., Trakhtenbrot, L., Paz, N., Koren-Michowitz, M., Waldman, D., Leider-Trejo, L., Toren, A., Constantini, S., and Rechavi, G. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6, e1000029, 2009.
140. Zhang, T., Lee, Y.W., Rui, Y.F., Cheng, T.Y., Jiang, X.H., and Li, G. Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res Ther 4, 70, 2013.
141. Luo, J., Ok Lee, S., Liang, L., Huang, C.K., Li, L., Wen, S., and Chang, C. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling. Oncogene 2013 [Epub ahead of print]; DOI: 10.1038/onc.2013.233.
142. Karnoub, A.E., Dash, A.B., Vo, A.P., Sullivan, A., Brooks, M.W., Bell, G.W., Richardson, A.L., Polyak, K., Tubo, R., and Weinberg, R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557, 2007.
143. Ferrand, J., Noel, D., Lehours, P., Prochazkova-Carlotti, M., Chambonnier, L., Menard, A., Megraud, F., and Varon, C. Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells. PLoS One 6, e19569, 2011.
144. Akimoto, K., Kimura, K., Nagano, M., Takano, S., To'a Salazar, G., Yamashita, T., and Ohneda, O. Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev 22, 1370, 2013.
145. Kim, D.W., Staples, M., Shinozuka, K., Pantcheva, P., Kang, S.D., and Borlongan, C.V. Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci 14, 11692, 2013.
146. Rachakatla, R.S., Marini, F., Weiss, M.L., Tamura, M., and Troyer, D. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther 14, 828, 2007.
147. Sun, B., Yu, K.R., Bhandari, D.R., Jung, J.W., Kang, S.K., and Kang, K.S. Human umbilical cord blood mesenchymal stem cell-derived extracellular matrix prohibits metastatic cancer cell MDA-MB-231 proliferation. Cancer Lett 296, 178, 2010.
148. Chao, K.C., Yang, H.T., and Chen, M.W. Human umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell-cell contact and internalization. J Cell Mol Med 16, 1803, 2011.
149. Ma, Y., Hao, X., Zhang, S., and Zhang, J. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Res Treat 133, 473, 2012.
150. Ayuzawa, R., Doi, C., Rachakatla, R.S., Pyle, M.M., Maurya, D.K., Troyer, D., and Tamura, M. Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett 280, 31, 2009.
151. Fan, C.G., Zhang, Q.J., and Zhou, J.R. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev 7, 195, 2011.
152. Gauthaman, K., Yee, F.C., Cheyyatraivendran, S., Biswas, A., Choolani, M., and Bongso, A. Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. J Cell Biochem 113, 2027, 2012.
153. Gauthaman, K., Fong, C.Y., Arularasu, S., Subramanian, A., Biswas, A., Choolani, M., and Bongso, A. Human Wharton's Jelly stem cell conditioned medium and cellfree lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice. J Cell Biochem 114, 366, 2013.
154. Gauthaman, K., Fong, C.Y., Suganya, C.A., Subramanian, A., Biswas, A., Choolani, M., and Bongso, A. Extraembryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells. Reprod Biomed Online 24, 235, 2012.
155. Liu, J., Han, G., Liu, H., and Qin, C. Correction: suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling. PLoS One 8: e6244, doi 10.1371/journal.pone.0062844.
156. Tian, K., Yang, S., Ren, Q., Han, Z., Lu, S., Ma, F., and Zhang, L. p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells. Cell Physiol Biochem 26, 799, 2010.
157. Anzalone, R., Lo Iacono, M., Loria, T., Di Stefano, A., Giannuzzi, P., Farina, F., and La Rocca, G. Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Stem Cell Rev 7, 342, 2011.
158. Hu, J., Yu, X., Wang, Z., Wang, F., Wang, L., Gao, H., Chen, Y., Zhao, W., Jia, Z., Yan, S., and Wang, Y. Long term effects of the implantation of Wharton's jellyderived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J 60, 347, 2013.
159. Chao, K.C., Chao, K.F., Fu, Y.S., and Liu, S.H. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS One 3, e1451, 2008.
160. Kim, S.J., Choi, Y.S., Ko, E.S., Lim, S.M., Lee, C.W., and Kim, D.I. Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation. J Biosci Bioeng 113, 771, 2012.
161. Hu, J., Wang, F., Sun, R., Wang, Z., Yu, X., Wang, L., Gao, H., Zhao, W., Yan, S., and Wang, Y. Effect of combined therapy of human Wharton's jelly-derived mesenchymal stem cells from umbilical cord with sitagliptin in type 2 diabetic rats. Endocrine 45, 279, 2014.
162. Molendijk, I., Duijvestein, M., van der Meulen-de Jong, A.E., van Deen, W.K., Swets, M., Hommes, D.W., and Verspaget, H.W. Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease. J Allergy (Cairo) 2012, 187408, 2012.
163. Garcia-Olmo, D., Herreros, D., Pascual, M., Pascual, I., De-La-Quintana, P., Trebol, J., and Garcia-Arranz, M. Treatment of enterocutaneous fistula in Crohn's disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. Int J Colorectal Dis 24, 27, 2009.
164. Ciccocioppo, R., Bernardo, M.E., Sgarella, A., Maccario, R., Avanzini, M.A., Ubezio, C., Minelli, A., Alvisi, C., Vanoli, A., Calliada, F., Dionigi, P., Perotti, C., Locatelli, F., and Corazza, G.R. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 60, 788, 2011.
165. Banerjee, R., Balaji, M., Sasikala, M., Anuradha, S., Rao, G.V., and Reddy, D.N. Granulomas of intestinal tuberculosis and Crohn's disease can be differentiated by CD73 cell surface marker expression: a pilot study. Dig Dis Sci 58, 2301, 2013.
166. Vernier, P., Moret, F., Callier, S., Snapyan, M., Wersinger, C., and Sidhu, A. The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system. Ann N Y Acad Sci 1035, 231, 2004.
167. Yan, M., Sun, M., Zhou, Y., Wang, W., He, Z., Tang, D., Lu, S., Wang, X., Li, S., and Li, H. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model. PLoS One 8, e64000, 2013.
168. Ribeiro, C.A., Fraga, J.S., Graos, M., Neves, N.M., Reis, R.L., Gimble, J.M., Sousa, N., and Salgado, A.J. The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Res Ther 3, 18, 2012.
169. Zhou, Y., Sun, M., Li, H., Yan, M., He, Z., Wang, W., and Lu, S. Recovery of behavioral symptoms in hemiparkinsonian rhesus monkeys through combined gene and stem cell therapy. Cytotherapy 15, 467, 2013.
170. Ye, M., Wang, X.J., Zhang, Y.H., Lu, G.Q., Liang, L., Xu, J.Y., and Chen, S.D. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease. Brain Res 1142, 206, 2007.
171. Auletta, J.J., Bartholomew, A.M., Maziarz, R.T., Deans, R.J., Miller, R.H., Lazarus, H.M., and Cohen, J.A. The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis. Immunotherapy 4, 529, 2012.
172. Payne, N.L., Sun, G., McDonald, C., Layton, D., Moussa, L., Emerson-Webber, A., Veron, N., Siatskas, C., Herszfeld, D., Price, J., and Bernard, C.C. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination. Cell Transplant 22, 1409, 2013.
173. Zhang, J., Li, Y., Chen, J., Cui, Y., Lu, M., Elias, S.B., Mitchell, J.B., Hammill, L., Vanguri, P., and Chopp, M. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 195, 16, 2005.
174. Zhang, J., Brodie, C., Li, Y., Zheng, X., Roberts, C., Lu, M., Gao, Q., Borneman, J., Savant-Bhonsale, S., Elias, S.B., and Chopp, M. Bone marrow stromal cell therapy reduces proNGF and p75 expression in mice with experimental autoimmune encephalomyelitis. J Neurol Sci 279, 30, 2009.
175. Ryu, C.H., Park, K.Y., Hou, Y., Jeong, C.H., Kim, S.M., and Jeun, S.S. Gene therapy of multiple sclerosis using interferon beta -secreting human bone marrow mesenchymal stem cells. Biomed Res Int 2013, 696738, 2013.
176. Liu, R., Zhang, Z., Lu, Z., Borlongan, C., Pan, J., Chen, J., Qian, L., Liu, Z., Zhu, L., Zhang, J., and Xu, Y. Human umbilical cord stem cells ameliorate experimental autoimmune encephalomyelitis by regulating immunoinflammation and remyelination. Stem Cells Dev 22, 1053, 2013.
177. Liang, J., Zhang, H., Hua, B., Wang, H., Wang, J., Han, Z., and Sun, L. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler 15, 644, 2009.
178. Liang, J., Wu, S., Zhao, H., Li, S.L., Liu, Z.X., Wu, J., and Zhou, L. Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into cholinergic-like neurons in vitro. Neurosci Lett 532, 59, 2013.
179. Katsuda, T., Tsuchiya, R., Kosaka, N., Yoshioka, Y., Takagaki, K., Oki, K., Takeshita, F., Sakai, Y., Kuroda, M., and Ochiya, T. Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 3, 1197, 2013.
180. Yang, H., Xie, Z., Wei, L., Yang, S., Zhu, Z., Wang, P., Zhao, C., and Bi, J. Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AbetaPP/PS1 transgenic mouse model. Stem Cell Res Ther 4, 76, 2013.